We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+12.98%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$95.4B
AUM Growth
+$9.26B
(+11%)
Cap. Flow
-$707M
Cap. Flow
% of AUM
-0.74%
Top 10 Holdings %
Top 10 Hldgs %
25.21%
Holding
4,380
New
32
Increased
1,513
Reduced
2,146
Closed
67
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 ETF
IWB
|
+$99.9M |
| 2 |
Uber
UBER
|
+$71M |
| 3 |
Broadcom
AVGO
|
+$36.2M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$32.6M |
| 5 |
lululemon athletica
LULU
|
+$32.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$139M |
| 2 |
Apple
AAPL
|
+$72.7M |
| 3 |
VMW
VMware, Inc
VMW
|
+$47.1M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$42.3M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$35.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.73% |
| 2 | Financials | 13% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 11.32% |
| 5 | Industrials | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
Aclaris Therapeutics
ACRS
$869M
| $101K | ﹤0.01% |
95,750
-6,684
| -7% | -$20.4K |
|
|
LTM
3202
DELISTED
LATAM Airlines Group S.A American Depositary Shares (Each representing 1 Common Share)
LTM
| $100K | ﹤0.01% |
169,770
+169,300
| +36,021% | +$99.9K |
|
3203
Pearson
PSO
$9.9B
| $99K | ﹤0.01% |
8,057
-112
| -1% | -$1.3K |
|
3204
Bank of Montreal
BMO
$127B
| $98.4K | ﹤0.01% |
995
-100
| -9% | -$8.35K |
|
3205
EVI Industries
EVI
$180M
| $98.2K | ﹤0.01% |
4,137
-101
| -2% | -$2.56K |
|
3206
TELA Bio
TELA
$38.9M
| $97.7K | ﹤0.01% |
14,766
+178
| +1% | +$1.03K |
|
|
LBPH
3207
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $97.6K | ﹤0.01% |
16,186
| – | – |
|
|
CCRD
3208
DELISTED
CoreCard
CCRD
| $97.3K | ﹤0.01% |
7,038
+73
| +1% | +$1.22K |
|
3209
Purple Innovation
PRPL
$41.7M
| $97.3K | ﹤0.01% |
3,777
-5
| -0.1% | -$128 |
|
3210
iShares S&P 100 ETF
OEF
$20.6B
| $96.7K | ﹤0.01% |
433
-3,144
| -88% | -$661K |
|
3211
Vor Biopharma
VOR
$1.28B
| $96.7K | ﹤0.01% |
2,150
-95
| -4% | -$3.92K |
|
3212
Maui Land & Pineapple Co
MLP
$344M
| $96.2K | ﹤0.01% |
6,055
-156
| -3% | -$2.3K |
|
|
MOMO
3213
Hello Group
MOMO
$866M
| $95.5K | ﹤0.01% |
13,742
-195
| -1% | -$1.36K |
|
3214
NLI Holdings
NL
$317M
| $95.1K | ﹤0.01% |
16,954
+200
| +1% | +$1K |
|
3215
Torrid Holdings
CURV
$260M
| $94.2K | ﹤0.01% |
16,333
-2,664
| -14% | -$9.12K |
|
3216
PepGen
PEPG
$197M
| $94.1K | ﹤0.01% |
13,841
-808
| -6% | -$4.43K |
|
|
GPGI
3217
GPGI Inc
GPGI
$4.35B
| $94K | ﹤0.01% |
20,960
+244
| +1% | +$1.14K |
|
3218
Workhorse Group
WKHS
$36.3M
| $93.2K | ﹤0.01% |
86
+5
| +6% | +$5.98K |
|
3219
Vesta Real Estate
VTMX
$3.18B
| $92.7K | ﹤0.01% |
2,340
+1,965
| +524% | +$68.8K |
|
3220
Rallybio
RLYB
$85.8M
| $92.6K | ﹤0.01% |
4,845
-1
| -0% | -$24 |
|
3221
Ramaco Resources Class B
METCB
$408M
| $91.4K | ﹤0.01% |
7,405
+87
| +1% | +$1.07K |
|
|
SWKH
3222
DELISTED
SWK Holdings
SWKH
| $91K | ﹤0.01% |
6,552
+72
| +1% | +$939 |
|
|
EGRX
3223
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $90.7K | ﹤0.01% |
17,341
+209
| +1% | +$2.06K |
|
|
WDH
3224
Waterdrop
WDH
$359M
| $90K | ﹤0.01% |
86,499
-10,635
| -11% | -$11.8K |
|
3225
CPI Card Group
PMTS
$320M
| $89.2K | ﹤0.01% |
4,647
| – | – |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2023 Portfolio in Review
As of Q4 2023, RhumbLine Advisers held 4,380 positions worth $95.4B, up 11% from $86.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 2.3%. RhumbLine Advisers opened 32 new positions and exited 67, leaving the 4,380-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2023 buy was CRH: 83,048 shares worth $5.74M.
- RhumbLine Advisers added most to iShares Russell 1000 ETF in Q4 2023, an estimated $99.9M increase.
- RhumbLine Advisers's biggest Q4 2023 reduction was Apple, cutting an estimated $72.7M.
- RhumbLine Advisers fully exited Activision Blizzard in Q4 2023, selling an estimated $139M.
- RhumbLine Advisers's ten largest holdings make up 25% of its $95.4B portfolio in Q4 2023.
- RhumbLine Advisers opened 32 new positions and closed 67 in Q4 2023.
- RhumbLine Advisers's portfolio value rose 11% quarter-over-quarter to $95.4B.
Based on RhumbLine Advisers's 13F filing for Q4 2023, filed 8 Feb 2024.